Results 131 to 140 of about 42,251 (222)

Adult Acute Myeloid Leukaemia With <i>DDX3X::MLLT10</i>: A Rare Entity With Significant Unmet Clinical Needs. [PDF]

EJHaem
Ng JY, Sr A, Joshi M, Talaulikar D.
europepmc   +1 more source

Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review. [PDF]

Ann Hematol
Ng JY, Gullapalli V, Othman J, Talaulikar D.   +3 more
europepmc   +1 more source

Clinical features and incidence of central nervous system involvement in patients with adult T‐cell leukaemia/lymphoma

British Journal of Haematology, Volume 208, Issue 3, Page 947-953, March 2026.
Summary Central nervous system (CNS) involvement is a known complication of adult T‐cell leukaemia/lymphoma (ATL), but its clinical characteristics and incidence still remain unclear. This study characterized the clinical features and incidence of CNS involvement in patients with ATL (CNS‐ATL).
Takuya Ueno, Makoto Yoshimitsu, Momone Sameshima, Taichi Nagano, Rika Akahoshi, Yusetsu Takeshita, Aya Shodai, Kodai Shima, Naosuke Arima, Yuhei Kamada, Daisuke Nakamura, Kenji Ishitsuka   +11 more
wiley   +1 more source

Case Report: FIA plus venetoclax in a patient on hemodialysis. [PDF]

Front Oncol
Herstein JE, Marx KR, Savoy JM, Jen WY, Yilmaz M, Short NJ, Issa GC, Ravandi F, Kadia TM, Daver NG, DiNardo CD.   +10 more
europepmc   +1 more source

Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practice

British Journal of Haematology, Volume 208, Issue 3, Page 981-991, March 2026.
Summary Febrile neutropenia causes substantial morbidity in acute myeloid leukaemia and higher risk myelodysplastic syndrome. We aimed to describe current practice and priorities for clinical trials in the prevention and management of febrile neutropenia across Australia/New Zealand (ANZ), the United Kingdom (UK), Canada and Europe.
Aleece MacPhail, Justin Loke, Brett L. Houston, Claire Dendle, Andrea S. Henden, Robert Weinkove, Orla Morrissey, Dionysios Neofytos, Niccolò Buetti, Catriona Parker, Monica A. Slavin, Charles Craddock, Simon J. Stanworth, Zoe McQuilten, on behalf of the Australasian Leukaemia and Lymphoma Group Supportive Care Working Group and UK AML/Supportive Care Working Parties   +14 more
wiley   +1 more source

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease. [PDF]

Blood Adv
Berman JN, Verma A, Viola S, Alonzo TA, Wang YC, Brodersen LE, Loken M, Beckman A, Hirsch B, Raimondi S, Chisholm KM, Ma X, Ries R, Meshinchi S, Gamis A, Schore R, Taub JW, Kolb EA, Cooper T, Hitzler J.   +19 more
europepmc   +1 more source

Targeting Genome Maintenance Defects of Cancers Using Chain‐Terminating Nucleoside Analogs

Cancer Science, Volume 117, Issue 3, Page 587-596, March 2026.
Nucleoside analogs interfere with DNA replication either by their chain‐terminating properties or by serving as DNA damage on the template. The genome maintenance pathways required to maintain cellular tolerance to each nucleoside analog vary depending on the drug.
Ryotaro Kawasumi, Rubaiat E. Tabassum, Kouji Hirota   +2 more
wiley   +1 more source

CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia. [PDF]

Int J Mol Sci
Konstantinidis I, Tsokkou S, Keramas A, Gavriilaki E, Delis G, Papamitsou T.   +5 more
europepmc   +1 more source

Utility of Cytochemical and Flow Cytometry Detection of Alkaline Phosphatase for Differential Diagnosis of CD34+ Acute Leukaemia in Canines

Veterinary and Comparative Oncology, Volume 24, Issue 1, Page 41-50, March 2026.
ABSTRACT Alkaline phosphatase (ALP) enzymatic activity has been proposed as a marker for distinguishing canine acute leukaemia (AL) subtypes (i.e., myeloid vs. lymphoid). However, ALP enzymatic activity has not been fully evaluated in CD34+ AL. Determine whether ALP enzymatic activity can differentiate CD34+ AL subtypes in dogs and distinguish CD34+ AL
Megan Aalto, Janna Yoshimoto, Jillian Nolan, Kenzie Olsen, Dylan Ammons, Emily Rout, Anne C. Avery, R. Adam Harris   +7 more
wiley   +1 more source

Treatment of Burkitt lymphoma in real-world setting: findings on 104 consecutive cases diagnosed and treated in Kazakhstan over the last decade. [PDF]

Ann Hematol
Jazyltayeva A, Shokun N, Umutbayeva A, Conte L, Ramazanova R, Kemaikin V, Karabekov A, Shalabay A, Koshkarbayeva A, Kemelbekov N, Zhumabay M, Shokubayeva F, Stepanihyna Y, Federico M, Gabbasova S.   +14 more
europepmc   +1 more source